Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1996-11-13
1998-12-29
Stucker, Jeffrey
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
4241411, 4241471, 4241591, 4241861, 4242291, 435 71, 435 693, 436548, 5303881, 5303883, 5303891, 536 2372, C07K 1608, A61K 39245, G01N 3350, C07H 2104
Patent
active
058543988
ABSTRACT:
This invention provides an antibody specific to the peptide of KSHVIL-6.
REFERENCES:
patent: 5188828 (1993-02-01), Goldberg et al.
patent: 5217881 (1993-06-01), Park
patent: 5264209 (1993-11-01), Mikayama et al.
patent: 5300292 (1994-04-01), Ulich
patent: 5338833 (1994-08-01), Fowlkes
patent: 5338834 (1994-08-01), Williams
patent: 5359034 (1994-10-01), Skelly et al.
patent: 5376368 (1994-12-01), Ulich
patent: 5470824 (1995-11-01), Miles et al.
Moore et al. J Virol, vol. 70, No. 1, Jan. 1996 pp. 549-558.
Miller et al. New Eng. J. Med. vol. 334, No. 20, May 16, 1996, p. 1292-1297.
Albrecht et al (1992) Primary structure of the herpesvirus saimiri genome, J Virol 66, 5047-5058.
Almeida et al (1994) Human cytomegalovirus alters interleukin-6 production by endothelial cells, Blood 83, 370-376.
Birkenbach et al (1993) Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors, J Virol 67, 2209-2220.
Tur and Brenner (Mar. 1996) Treatment of Kaposi's sarcoma, Arch Dermatol 132, 327-331.
Chee et al (1995) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169, Curr Top Microbiol Immunol 154, 125-169.
Cleary et al (1986) Cloning and structural analysis of cDNAs for bc1-2 and a hybrid bc1-2/immunoglobulin transcript resulting from the t (14; 18) translocation, Cell 47, 19-28.
Cohen et al (Jan. 12, 1996) Interleukin 6 induces the expression of vascular endothelial growth factor, J Biol Chem 271, 736-741.
Ensoli et al (1992) Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma, Immunol Reviews 127, 147-155.
Finke et al (1992) Expression bc1-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes, Blood 80, 459-469.
Finke et al (1994) Bc1-2 induction is part of the strategy of Epstein-Barr virus, Leuk Lymphoma 12, 413-419.
Gao and Murphy (1994) Human cytomegalovirus open reading fram US28 encodes a functional bata chemokine receptor, J Biol Chem 269, 28539-28542.
Holzinger et al (1993) Effects of interleukin-1, -2, -4, -6, inter-feron-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells, Immunol Lett 35, 109-117.
Jones et al (1995) Infection of human endothelial cells with Epstein-Barr virus, J Exp Med 182, 1213-1221.
Lafeuillade et al (Jan. 1996) IL-6 and b-FGF overproductions precede development of AIDS-associated Kaposi's sarcoma, J AIDS Hum Retrovirol 12, 95.
Larcher et al (1995) Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21, Eur J Immunol 25, 1713-1719.
Lichtenstein et al (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells, Cellular Immunology 162, 248-255.
Massung et al (1994) Analysis of the complete genome of smallpox variola major virus strain bangladesh-1975, Virol 201, 215-240.
Palmero et al (1993) Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines, Oncogene 8, 1049.
Scala et al (1990) Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantgae and in vivo tumorigenicity, J Exp Med 172, 61-68.
Renne et al (Mar. 1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture, Nat Med 2, 342-346.
Shen and Shenk (1995) Viruses and apoptosis, Cur Opin Genet Dev 5, 105-111.
Weiss (Mar. 1996) Human herpesvirus 8 in lymphoma and Kaposi's sarcoma: now the virus can be propagated, Nat Med 2, 277-278.
Tosato et al (1990) Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells, J Virol 64, 3033-3041.
Zhong et al (Jun 25, 1996) Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma, Proc Natl Acad Sci USA 93, 6641-6646.
Armstrong et al. (1994) Melanoma-derived interleukin 6 inhibits in vivo melanoma growth, J. Invest. Dermatol 102, 278-284.
Burger et al. (1994) Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop, Annals Hematol. 69, 25-31.
Emilie et al. (1992) Production of interleukin-6 in high grade B lymphomas, Curr. Top. Microbiol Immunol 182, 349-355.
Evans et al. (1992) Tumor cell IL-6 gene expression is regulated by IL-1alpha/beta and TNFalpha: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages, J. Leukocyte Biol. 52, 463-468.
Karp and Broder (1991) Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas, Cancer Research 51, 4743-4756.
Klein (1995) Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma, Semin. Hematol. 32, 4-19.
Lotz (1993) Interleukin-6, Cancer Invest. 11, 732-742.
Rifas et al. (1995) Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids, Endocrinology 136, 4056-4067.
Tan et al. (1990) Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts, J. Rheumatol 17, 1608-1612.
Yuan et al. (1994) The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements, Mol. Cell Biol. 14, 1657-1668.
Gao et al. (1996) Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma, New Eng. J. Med. 335, 233-241 (Exhibit 2).
Kedes et al. (1996) The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission, Nature Medicine 2, 918-924 (Exhibit 3).
Gao et al. (1996) KSHV antibodies among Amnericans, Italians and Ugandans with and without Kaposi's sarcoma, Nature Medicine 2, 925-928 (Exhibit 4).
Bohenzky Roy A.
Chang Yuan
Edelman Isidore S.
Moore Patrick S.
Russo James J.
Bui Phuong T.
Stucker Jeffrey
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425888